Impact of COVID-19 on gut–lung microbiota a mini review DOI

Reza Emadi,

Parastoo Yousefi, Alireza Tabibzadeh

и другие.

Reviews in Medical Microbiology, Год журнала: 2024, Номер unknown

Опубликована: Дек. 27, 2024

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes disease 2019 (COVID-19) affects the lungs and gastrointestinal tract. However, SARS-CoV-2 chiefly infects through binding of angiotensin-converting enzyme (ACE2) receptors type II transmembrane serine protease (TMPRSS2) expressed on alveolar epithelial cells. Furthermore, intestinal cells also express ACE2 receptors. Not only has been detected in nasopharyngeal mid-nasal samples, but it seems RNA can be found feces infectious patients. In fact, fecal samples patients contain virus. intensity COVID-19 mainly associated with aging comorbidities. Older experience a decline alteration gut microbiome, proven to most fatal this age group, further emphasizing potential critical role microbiota disease. lung was formerly believed sterile area free from bacteria. microbiome received more attention due its recent link several illnesses immunity. review article, data research gut–lung cross-talk prognosis explored bidirectional impacts axis were discussed.

Язык: Английский

Gut microbiota in neurological diseases: Melatonin plays an important regulatory role DOI Open Access
Somayeh Ahmadi, Mohammad Taghizadieh, Elham Mehdizadehfar

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 174, С. 116487 - 116487

Опубликована: Март 21, 2024

Melatonin is a highly conserved molecule produced in the human pineal gland as hormone. It known for its essential biological effects, such antioxidant activity, circadian rhythm regulator, and immunomodulatory effects. The gut one of primary sources melatonin. microbiota helps produce melatonin from tryptophan, has been shown to have beneficial effect on barrier function microbial population. Dysbiosis intestinal associated with bacterial imbalance decreased metabolites, including In this way, low levels may be related several diseases. both preventive therapeutic effects against various conditions, neurological diseases Alzheimer's disease, Parkinson's multiple sclerosis. This review was aimed discuss role body, describe possible relationship between production, well potential

Язык: Английский

Процитировано

21

Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance DOI Creative Commons
Hiva Kadkhoda, Pourya Gholizadeh, Hossein Samadi Kafil

и другие.

Heliyon, Год журнала: 2024, Номер 10(14), С. e34692 - e34692

Опубликована: Июль 1, 2024

The emergence and development of antibiotic resistance in bacteria is a serious threat to global public health. Antibiotic genes (ARGs) are often located on mobile genetic elements (MGEs). They can be transferred among by horizontal gene transfer (HGT), leading the spread drug-resistant strains treatment failure. CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated genes) one many strategies have developed under long-term selection pressure restrict HGT. CRISPR-Cas systems exist about half bacterial genomes play significant role limiting resistance. On other hand, bacteriophages MGEs encode wide range anti-CRISPR proteins (Acrs) counteract immunity system. Acrs could decrease system's activity against phages facilitate acquisition ARGs virulence traits for bacteria. This review aimed assess relationship between with We also highlighted technology control prevent antibacterial system target nucleic acid sequences high accuracy reliability; therefore, it has become novel editing therapy tool CRISPR-based approaches may pave way developing smart antibiotics, which eliminate multidrug-resistant (MDR) distinguish pathogenic beneficial microorganisms. Additionally, engineered gene-containing combination antibiotics used as cutting-edge approach reduce

Язык: Английский

Процитировано

10

Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19 DOI Creative Commons
Patrícia Brito Rodrigues, Vinícius de Rezende Rodovalho, Valentin Sencio

и другие.

Gut Microbes, Год журнала: 2025, Номер 17(1)

Опубликована: Апрель 2, 2025

Aging is a key contributor of morbidity and mortality during acute viral pneumonia. The potential role age-associated dysbiosis on disease outcomes still elusive. In the current study, we used high-resolution shotgun metagenomics targeted metabolomics to characterize SARS-CoV-2-associated changes in gut microbiota from young (2-month-old) aged (22-month-old) hamsters, valuable model COVID-19. We show that age-related dysfunctions are linked severity long-term sequelae older hamsters. Our data also reveal age-specific composition metabolic activity both phase (day 7 post-infection, D7) recovery (D22) infection. Aged hamsters exhibited most notable shifts plasma profiles. Through an integrative analysis metagenomics, metabolomics, clinical data, identified significant associations between bacterial taxa, metabolites markers group. On D7 (high load lung epithelial damage) D22 (body weight loss fibrosis), numerous amino acids, acid-related molecules, indole derivatives were found correlate with markers. particular, persistent decrease phenylalanine, tryptophan, glutamic acid, indoleacetic acid animals positively correlated poor body and/or fibrosis by D22. younger several taxa (Eubacterium, Oscillospiraceae, Lawsonibacter) (carnosine cis-aconitic acid) associated mild outcomes. These findings support need for microbiome-targeting strategies more effectively manage pneumonia

Язык: Английский

Процитировано

0

Effects of pectin-type polysaccharides derived from Houttuynia cordata on the intestinal immune system in native C3H/HeN mice DOI

So Min Kim,

Hyun Young Shin,

Se Hyeon Sim

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер unknown, С. 142995 - 142995

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

The Relationship Between Gut Microbiota and Preterm Premature Rupture of Membranes: Mechanisms of Action and Clinical Applications DOI
Somayeh Ahmadi,

Maryam Alikamali,

Javad Nezhadi

и другие.

Microbial Pathogenesis, Год журнала: 2025, Номер 205, С. 107673 - 107673

Опубликована: Май 6, 2025

Язык: Английский

Процитировано

0

Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in experimental COVID-19 DOI Open Access
Patrícia Brito Rodrigues, Vinícius de Rezende Rodovalho, Valentin Sencio

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Ноя. 6, 2024

Abstract Aging is a key contributor of morbidity and mortality during acute viral pneumonia. The potential role age-associated dysbiosis on disease outcomes still elusive. In the current study, we used high-resolution shotgun metagenomics targeted metabolomics to characterize SARS-CoV-2-associated changes in gut microbiota from young (2-month-old) aged (22-month-old) hamsters, valuable model COVID-19. We show that age-related dysfunctions are linked severity long-term sequelae older hamsters. Our data also reveal age-specific composition metabolic activity both phase (day 7 post-infection, D7) recovery (D22) infection. Aged hamsters exhibited most notable shifts plasma profiles. Through an integrative analysis metagenomics, metabolomics, clinical data, identified significant associations between bacterial taxa, metabolites markers group. On D7 (high load lung epithelial damage) D22 (body weight loss fibrosis), numerous amino acids, acid-related molecules, indole derivatives were found correlate with markers. particular, persistent decrease phenylalanine, tryptophan, glutamic acid, indoleacetic acid animals positively correlated poor body and/or fibrosis by D22. younger several taxa ( Eubacterium , Oscillospiraceae Lawsonibacter ) (carnosine cis-aconitic acid) associated mild outcomes. These findings support need for microbiome-targeting strategies more effectively manage pneumonia

Язык: Английский

Процитировано

1

Impact of COVID-19 on gut–lung microbiota a mini review DOI

Reza Emadi,

Parastoo Yousefi, Alireza Tabibzadeh

и другие.

Reviews in Medical Microbiology, Год журнала: 2024, Номер unknown

Опубликована: Дек. 27, 2024

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes disease 2019 (COVID-19) affects the lungs and gastrointestinal tract. However, SARS-CoV-2 chiefly infects through binding of angiotensin-converting enzyme (ACE2) receptors type II transmembrane serine protease (TMPRSS2) expressed on alveolar epithelial cells. Furthermore, intestinal cells also express ACE2 receptors. Not only has been detected in nasopharyngeal mid-nasal samples, but it seems RNA can be found feces infectious patients. In fact, fecal samples patients contain virus. intensity COVID-19 mainly associated with aging comorbidities. Older experience a decline alteration gut microbiome, proven to most fatal this age group, further emphasizing potential critical role microbiota disease. lung was formerly believed sterile area free from bacteria. microbiome received more attention due its recent link several illnesses immunity. review article, data research gut–lung cross-talk prognosis explored bidirectional impacts axis were discussed.

Язык: Английский

Процитировано

0